Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy

Published:2015-12-01 Issue:12 Volume:100 Page:4588-4594
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Mikkola Tomi S.¹²,Tuomikoski Pauliina¹,Lyytinen Heli³,Korhonen Pasi³,Hoti Fabian³,Vattulainen Pia³,Gissler Mika⁴⁵,Ylikorkala Olavi¹

Affiliation:

1. Department of Obstetrics and Gynecology (T.S.M., P.T., O.Y.), Helsinki University Hospital, 00029 Helsinki, Finland

2. Folkhälsan Research Center (T.S.M.), 00250 Helsinki, Finland

3. EPID Research Oy (H.L., P.K., F.H., P.V.), 02130 Espoo, Finland

4. National Institute for Health and Welfare (M.G.), 00271 Helsinki, Finland

5. Nordic School of Public Health (M.G.), 40242 Gothenburg, Sweden

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/100/12/4588/10422898/jcem4588.pdf

Reference39 articles.

1. Hormone therapy to prevent disease and prolong life in postmenopausal women;Grady;Ann Intern Med,1992

2. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease;Grodstein;Ann Intern Med,2000

3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group;Hulley;JAMA,1998

4. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial;Rossouw;JAMA,2002

5. Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study;Bretler;BMJ,2012

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury;Biomedicine & Pharmacotherapy;2024-07

2. Perimenopause Decreases SERCA2a Activity in the Hearts of a Mouse Model of Ovarian Failure;Biomolecules;2024-06-09

3. From cardiovascular protection to cardiovascular risk: the metamorphosis of menopausal hormone therapy;Reproduction, Fertility and Development;2024-06-03

4. The association study of body composition and hormone levels with glucose, lipid and bone density in perimenopausal and postmenopausal women;2024-03-19

5. Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population;American Journal of Transplantation;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3